Neuroinflammation-induced lymphangiogenesis in the CNS
中枢神经系统中神经炎症诱导的淋巴管生成
基本信息
- 批准号:10224352
- 负责人:
- 金额:$ 37.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAntibodiesAntigen-Presenting CellsAntigensAreaAstrocytesAutoimmunityAutomobile DrivingBiologicalBrainCD44 AntigensCNS autoimmunityCellsCentral Nervous System DiseasesCervical lymph node groupCharacteristicsClinicalDataDendritic CellsDevelopmentDiseaseDrainage procedureDura MaterEndothelial CellsExperimental Autoimmune EncephalomyelitisFlow CytometryFluid BalanceFunctional disorderGene Expression ProfileGlial Fibrillary Acidic ProteinHeterogeneityITGAX geneImmuneImmunohistochemistryIn SituInflammatoryLigandsLiquid substanceLymphangiogenesisLymphaticLymphatic Endothelial CellsLymphedemaLymphoidLymphoid CellMediatingMultiple SclerosisMusMyeloid Progenitor CellsNeuronsOligodendrogliaPathogenesisPathogenicityPathologicPathologyPathway interactionsPeripheralPharmacologyProteinsReceptor Protein-Tyrosine KinasesRegulationRegulatory PathwayReporterRoleSculptureSourceSpinal CordStrokeT-LymphocyteTestingTherapeuticTimeTissuesTransgenic MiceTransgenic OrganismsTraumaTyrosine Kinase InhibitorVEGFC geneVascular Endothelial Growth Factor Receptor-3Workadaptive immunitycribriform platedraining lymph nodein vivo imaginginflammatory milieulymph nodeslymphatic vesselmacrophagemonocytemouse modelnestin proteinneuroinflammationpodoplaninrecruittargeted treatmenttesting accesstranscription factor
项目摘要
PROJECT SUMMARY/ABSTRACT
Adaptive immunity in most tissues of the body involves the drainage of antigens or antigen presenting cells within
conventional lymphatic vessels to the draining lymph nodes where antigen is presented to T cells. However,
there are no conventional lymphatic vessels within the CNS parenchyma. Alternatively, it has been hypothesized
that antigens, antigen presenting cells, and CSF may drain from the CNS into lymphatics near the cribriform
plate or dura to maintain fluid homeostasis and antigen drainage during steady-state conditions, yet little is known
about the role of these lymphatic vessels during neuroinflammation.
We discovered that lymphatic vessels near the cribriform plate undergo extensive in situ neo-lymphangiogenesis
during experimental autoimmune encephalomyelitis (EAE), a mouse model of Multiple Sclerosis. Our preliminary
data show that these neo-lymphatic vessels near the cribriform plate are functionally able to drain both CSF and
cells that were once in the CNS parenchyma. We further found the during EAE, VEGFC protein is produced by
infiltrating macrophages and dendritic cells to promote VEGFR3 dependent neo-lymphangiogenesis near the
cribriform plate. These data are the first to describe neo-lymphangiogenesis near the cribriform plate during
neuroinflammation. The long-term objective of this project is to characterize the functionality and contribution
of newly formed lymphoid vessels near to the cribriform plate to autoimmunity and stroke of the CNS.
The specific objectives of this proposal are (1) to define the characteristics and regulatory mechanisms driving
neo-lymphangiogenesis near the cribriform plate (Aim 1); (2) to test the functionality of neo-lymphatic vessels
near the cribriform plate and compare them to different CNS area lymphatics (Aim 2); and (3) to understand the
translational value of exacerbating or inhibiting neo-lymphangiogenesis near the cribriform plate in order to treat
CNS diseases (Aim 3).
Pharmacological inhibition or exacerbation of neo-lymphangiogensis to modulate pathology in CNS diseases
may have potential therapeutic values for CNS autoimmunity and ischemic trauma.
项目总结/摘要
在身体的大多数组织中的适应性免疫涉及抗原或抗原呈递细胞内的引流。
传统淋巴管到引流淋巴结,在那里抗原被提呈给T细胞。然而,在这方面,
在CNS实质内没有常规的淋巴管。或者,有人假设
抗原、抗原提呈细胞和CSF可从CNS流入筛状结构附近的淋巴管,
板或硬脑膜,以维持流体稳态和抗原引流在稳态条件下,但知之甚少
这些淋巴管在神经炎症中的作用。
我们发现筛板附近的淋巴管经历了广泛的原位新淋巴管生成
在实验性自身免疫性脑脊髓炎(EAE),多发性硬化症的小鼠模型。我们的初步
数据显示,筛状板附近的这些新淋巴管在功能上能够排出CSF,
曾经在中枢神经系统实质中的细胞。我们进一步发现,在EAE期间,VEGFC蛋白由
浸润巨噬细胞和树突状细胞,以促进VEGFR 3依赖性新淋巴管生成,
筛板这些数据首次描述了在移植过程中筛板附近的新淋巴管生成。
神经炎症该项目的长期目标是确定
筛状板附近新生淋巴管对自身免疫和中枢神经系统卒中的影响。
本建议的具体目标是(1)确定驱动的特征和监管机制
筛板附近的新生淋巴管生成(目的1);(2)检测新生淋巴管的功能
筛状板附近,并将其与不同的CNS区域解剖学进行比较(目的2);以及(3)了解
加重或抑制筛板附近新淋巴管生成的转化价值,
CNS疾病(目标3)。
药理学抑制或加重新淋巴管生成以调节CNS疾病的病理
可能对中枢神经系统自身免疫和缺血性创伤具有潜在的治疗价值。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zsuzsanna Fabry其他文献
Zsuzsanna Fabry的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zsuzsanna Fabry', 18)}}的其他基金
Regulation of Neuroinflammation by Meningeal Lymphatics
脑膜淋巴管对神经炎症的调节
- 批准号:
10581900 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
Regulation of Neuroinflammation by Meningeal Lymphatics
脑膜淋巴管对神经炎症的调节
- 批准号:
10682552 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
Graduate Training in Cellular and Molecular Pathogenesis of Human Diseases
人类疾病的细胞和分子发病机制研究生培训
- 批准号:
10187600 - 财政年份:2020
- 资助金额:
$ 37.61万 - 项目类别:
Graduate Training in Cellular and Molecular Pathogenesis of Human Diseases
人类疾病的细胞和分子发病机制研究生培训
- 批准号:
10620761 - 财政年份:2020
- 资助金额:
$ 37.61万 - 项目类别:
Graduate Training in Cellular and Molecular Pathogenesis of Human Diseases
人类疾病的细胞和分子发病机制研究生培训
- 批准号:
10413879 - 财政年份:2020
- 资助金额:
$ 37.61万 - 项目类别:
Neuroinflammation-induced lymphangiogenesis in the CNS
中枢神经系统中神经炎症诱导的淋巴管生成
- 批准号:
9769903 - 财政年份:2018
- 资助金额:
$ 37.61万 - 项目类别:
Neuroinflammation-induced lymphangiogenesis in the CNS
中枢神经系统中神经炎症诱导的淋巴管生成
- 批准号:
10449330 - 财政年份:2018
- 资助金额:
$ 37.61万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 37.61万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 37.61万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 37.61万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 37.61万 - 项目类别:














{{item.name}}会员




